Desiree Matthews
Psychiatric/Mental Health · Charlotte, NCNPI 1356700561
Payments from drug & device makers
Across 1,082 payments — averaging $745.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$331K
- E.r. Squibb & Sons, L.L.C.$103K
- Teva Pharmaceuticals USA, Inc.$100K
- Johnson & Johnson$71K
- AbbVie$58K
- Axsome Therapeutics, Inc.$39K
- plus $104K from 14 others
What the payments were for
- Consulting fees$231,00529%
- Speaking & faculty fees$454,87256%
- Travel & lodging$100,56312%
- Food & beverage$20,2083%
- Education$2310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 409 | $330,713 |
| E.r. Squibb & Sons, L.L.C. | 97 | $103,034 |
| Teva Pharmaceuticals USA, Inc. | 137 | $100,495 |
| Johnson & Johnson | 77 | $70,765 |
| AbbVie(2 entities) | 123 | $58,131 |
| Axsome Therapeutics, Inc. | 62 | $39,292 |
| Alkermes, Inc. | 34 | $18,793 |
| Indivior Inc. | 30 | $16,337 |
| Luye Pharma (USA) Ltd. | 9 | $11,523 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $10,376 |
| Otsuka America Pharmaceutical, Inc. | 21 | $9,469 |
| Biogen | 4 | $9,300 |
| Boehringer Ingelheim | 5 | $8,978 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 16 | $8,597 |
| Big Health Inc. | 9 | $4,980 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $2,412 |
| Janssen Scientific Affairs, LLC | 8 | $2,315 |
| Boehringer Ingelheim International GmbH | 3 | $1,240 |
| Sage Therapeutics, LLC | 1 | $79 |
| Supernus Pharmaceuticals, Inc. | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$321,300
- UZEDY$77,800
- INVEGA TRINZA$70,048
- INVEGA SUSTENNA$69,681
- VRAYLAR$55,484
- ARISTADA$45,922
- COBENFY$40,791
- Auvelity$38,263
- Austedo XR$22,222
- LYBALVI$18,965
- PERSERIS$15,675
- ERZOFRI EXTENDED-RELEASE$11,523
- CAPLYTA$9,871
- ARISTADA INITIO$9,607
- REXULTI$5,824
- REJOYN$4,605
- TRINTELLIX$2,104
- AUSTEDO$112
How this compares
$806,878 in reported general payments places this provider in the 95th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Other psychiatric/mental health in Charlotte
- Benedetto PalomboCharlotte$671K
- Carol Cameron MatthewsCharlotte$12K
- Rohan MatthewsCharlotte$8K
- Carli GastleyCharlotte$8K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.